Viveve Medical (VIVE) Shares Gap Up to $0.69

Share on StockTwits

Viveve Medical Inc (NASDAQ:VIVE)’s share price gapped up prior to trading on Monday . The stock had previously closed at $0.76, but opened at $0.69. Viveve Medical shares last traded at $0.62, with a volume of 9096 shares trading hands.

Several equities analysts recently issued reports on the company. Mizuho reiterated a “buy” rating and issued a $4.00 price objective on shares of Viveve Medical in a research report on Friday, March 15th. Maxim Group reiterated a “buy” rating and issued a $6.00 price objective on shares of Viveve Medical in a research report on Monday, February 11th. Finally, Craig Hallum set a $1.00 price objective on Viveve Medical and gave the company a “hold” rating in a research report on Friday, January 18th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $4.00.

The company has a quick ratio of 3.51, a current ratio of 3.89 and a debt-to-equity ratio of 6.21. The stock has a market cap of $26.84 million, a PE ratio of -0.38 and a beta of 0.70.

Several institutional investors and hedge funds have recently modified their holdings of VIVE. Nantahala Capital Management LLC grew its position in shares of Viveve Medical by 66.7% in the 4th quarter. Nantahala Capital Management LLC now owns 6,581,465 shares of the company’s stock valued at $6,911,000 after purchasing an additional 2,633,333 shares during the period. RTW Investments LP boosted its position in Viveve Medical by 42.4% during the 4th quarter. RTW Investments LP now owns 4,480,565 shares of the company’s stock worth $4,705,000 after acquiring an additional 1,333,333 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Viveve Medical by 266.6% during the 4th quarter. Bank of New York Mellon Corp now owns 45,223 shares of the company’s stock worth $47,000 after acquiring an additional 32,888 shares during the last quarter. Sargent Investment Group LLC acquired a new position in Viveve Medical during the 4th quarter worth approximately $32,000. Finally, Geode Capital Management LLC boosted its position in Viveve Medical by 13.6% during the 4th quarter. Geode Capital Management LLC now owns 216,566 shares of the company’s stock worth $227,000 after acquiring an additional 25,975 shares during the last quarter. Institutional investors and hedge funds own 60.99% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Viveve Medical (VIVE) Shares Gap Up to $0.69” was posted by Week Herald and is the property of of Week Herald. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://weekherald.com/2019/04/15/viveve-medical-vive-shares-gap-up-to-0-69.html.

Viveve Medical Company Profile (NASDAQ:VIVE)

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories.

Recommended Story: How do candlesticks reflect price movement?

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.